Rare diseases
Investigational molecules
Locations
Back to Germany21 clinical trials in Velbert, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive studies focusing on HR-positive, HER2-negative breast cancer treatments, including both early-stage and metastatic cases. Research encompasses novel therapeutic combinations and treatment optimization strategies.
Multiple trials are evaluating innovative approaches for improving patient outcomes and survival rates.
Groundbreaking research into non-small cell lung cancer (NSCLC) treatments, with particular emphasis on immunotherapy and combination approaches for metastatic disease.
Studies aim to enhance treatment efficacy and patient survival rates through innovative therapeutic approaches.
Research focusing on blood disorders, particularly chronic myeloid leukemia and related conditions. Studies evaluate novel therapeutic agents and treatment strategies.
Investigations aim to improve treatment outcomes and quality of life for patients with blood disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
